These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9324787)

  • 61. [The relationship between the pathogenetic mechanisms of effort stenocardia and the pharmacodynamics of anti-anginal agents].
    Kuleshova EV; Tsyrlin VA; Moroshkin VS; Lopukhov AA; Lokhovinina NL; Antonova IS
    Kardiologiia; 1993; 33(8):23-5. PubMed ID: 8121126
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
    Skibitskiĭ VV
    Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effects of inhibitors of the angiotensin-converting enzyme on endothelial dysfunction in patients with stable angina pectoris].
    Volkov VI; Abidova KR
    Lik Sprava; 2001; (3):62-5. PubMed ID: 11560030
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Urolesan in the treatment of stenocardia patients].
    Neĭko EM; Duma ZV; Del'va IuV; Shpak BIu; Debenko MV
    Vrach Delo; 1989 Nov; (11):57-9. PubMed ID: 2609587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The renin-angiotensin-aldosterone system and cardiac ischaemia.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):60-7. PubMed ID: 8983666
    [No Abstract]   [Full Text] [Related]  

  • 66. [A method for optimizing the finoptin treatment of patients with ischemic heart disease].
    Synchuk AN; Chursina TIa; Rozgon GI; Troian NF; Kiriliuk NA; Glibka AZ
    Lik Sprava; 1995; (3-4):140-2. PubMed ID: 8819947
    [No Abstract]   [Full Text] [Related]  

  • 67. [Predicting the efficacy of antianginal therapy].
    Dechko EP; Savel'ev MA
    Vrach Delo; 1990 Jun; (6):5-7. PubMed ID: 2399722
    [No Abstract]   [Full Text] [Related]  

  • 68. [The prognosis of drug therapy efficacy in ventricular rhythm disorders by the level of intracellular Ca2+ in the lymphocytes of patients with ischemic heart disease].
    Liusov VA; Volov NA; Dibirova GO; Uteshev DB
    Kardiologiia; 1993; 33(9):36-8. PubMed ID: 8145439
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effects of coenzyme Q10 injections on exercise tolerance in patients with stable angina pectoris].
    Hiasa Y; Ishida T; Maeda T; Iwano K; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1983 Apr; 31(4):419-23. PubMed ID: 6867496
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of ACE inhibitors on coronary haemodynamics and angina pectoris.
    Davies MK
    Br Heart J; 1994 Sep; 72(3 Suppl):S52-6. PubMed ID: 7946804
    [No Abstract]   [Full Text] [Related]  

  • 71. [Angiotensin I converting enzyme inhibitors in ischemic cardiopathy].
    Ribeiro C
    Rev Port Cardiol; 1991 Apr; 10(4):345-53. PubMed ID: 1888525
    [No Abstract]   [Full Text] [Related]  

  • 72. Lack of effect of disopyramide on chronic stable angina.
    Lahiri A; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1981; 3(1):215-6. PubMed ID: 6160351
    [No Abstract]   [Full Text] [Related]  

  • 73. [Change in the coagulation and anticoagulation systems of the blood in patients with coronary cardiosclerosis with symptoms of stenocardia in treatment with heparin electrophoresis].
    Glagoleva NA; Shubina AV
    Ter Arkh; 1967 Sep; 39(9):88-93. PubMed ID: 5611710
    [No Abstract]   [Full Text] [Related]  

  • 74. [The stress-modulating effects of laser therapy in IHD patients].
    Barbarash OL; Martsiiash AA; Sheĭbak TV; Chukaeva II; Korochkin IM; Syrnev VV
    Ter Arkh; 1996; 68(12):50-3. PubMed ID: 9054041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Leukotriene inhibitors in cardiological practice].
    Trybrat TA
    Lik Sprava; 1997; (3):117-9. PubMed ID: 9377329
    [No Abstract]   [Full Text] [Related]  

  • 76. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
    Lizogub VG; Chumak AA; Savchenko AV; Pliskevich DA
    Lik Sprava; 2000; (3-4):31-4. PubMed ID: 10921255
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [On the treatment of stenocardia pains following heart infarct].
    Wolkerstorfer H
    Wien Klin Wochenschr; 1965 Dec; 77(51):1012-4. PubMed ID: 5331454
    [No Abstract]   [Full Text] [Related]  

  • 78. [Dynamics of immunologic indices in patients with ischemic heart disease on a course of doxazosin therapy].
    Lyzohub VH; Savchenko OV; Chumak AA; Dykukha IS
    Lik Sprava; 2003; (5-6):85-9. PubMed ID: 14618814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
    Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
    Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Experience with the use of leech therapy at a health resort on patients with hypertension and ischemic heart disease].
    Zarodova EV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (4):38-9. PubMed ID: 8236927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.